Genveon İlaç Rebrands on Social Media

Genveon İlaç, which has brought innovative products to Turkey's pharmaceutical market and recently acquired Novartis's Gebze manufacturing facility, has completed its transformation initiative, launched alongside its growth trajectory, with new social media accounts. With a broad product portfolio comprising original, generic and OTC pharmaceuticals in both acute and chronic markets, Genveon İlaç touches people's lives and is opening its doors to the digital world through newly established social media accounts, reflecting its renewed vision and image. Within the scope of its transformation initiative launched as of 2020 in line with its new targets, Genveon İlaç has undergone a name change and, with the acquisition of a best-in-class manufacturing facility, has entered the production sector. The company will announce all developments, innovations and achievements through its social media accounts. In addition to Genveon İlaç, you can follow LinkedIn, Twitter, Instagram, Facebook and Youtube accounts covering developments, achievements and innovations in Turkey's pharmaceutical sector via the links below. LinkedIn: https://tr.linkedin.com/company/genveonilac Twitter: https://twitter.com/genveonilac Instagram: https://www.instagram.com/genveonilac/ Facebook: https://www.facebook.com/genveonilac/ Youtube: https://www.youtube.com/channel/UCKec8eC7mYuCMjKiPjao2Ng